Use of QRX3 for Acute Tubular Necrosis Type of Renal Failure in Hospitalized Patients ( QRX-3 in ARF)

Starting soon · Phase 2/Phase 3 · Has a placebo group

Conditions studied: Acute Renal Failure (ARF), Acute Tubular Necrosis

In brief

Use of QRX-3 in hospitalized patients with pediatric and adult patients with acute tubular necrosis renal failure

Key facts

Study ID

NCT07161843

Run by

Ebima Clifford Okundaye

People needed

500

Starts

2026-06-30

Expected to finish

2027-02-01

Last updated by the study team

2026-02-18

Who can join

Age: 10 and older, up to 80. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Hospitalized patients
• presence of Acute renal failure
• Nephrologist diagnosis of Acute tubular necrosis or fractional excretion of sodium of >2%
• willingness to participate

You may not qualify if…

• High risk of bleeding Absence of hydronephrosis or obstructive uropathy Absence of baseline dialysis use single kidney status

Where it is running

• Neukidney Inc — Rosharon, Texas, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.